Complications of Candidemia in ICU Patients: Endophthalmitis, Osteomyelitis, Endocarditis

 

 Buy Article Permissions and Reprints

Abstract

Bloodstream infection with Candida species is not uncommon in the intensive care unit setting and has the potential to distribute organisms to many different organ systems causing secondary infections, such as endophthalmitis, osteomyelitis, and endocarditis. In some patients, these types of infections become manifested shortly after the episode of candidemia. In others, especially vertebral osteomyelitis, weeks pass before the diagnosis is entertained. Endophthalmitis should be sought by a retinal examination in all patients early after an episode of candidemia. Both osteomyelitis and endocarditis are less common complications of candidemia than endophthalmitis. In patients who manifest symptoms or signs suggesting these infections, magnetic resonance imaging and transesophageal echocardiography, respectively, are extremely helpful diagnostic tests. Newer approaches to the treatment of these infections allow the use of better tolerated, safer antifungal agents. Endophthalmitis is often treated with fluconazole or voriconazole, and the echinocandins are increasingly used, instead of amphotericin B, as initial therapy for osteomyelitis and endocarditis before step-down therapy to oral azole agents.

• References

• 1 Binder MI, Chua J, Kaiser PK, Procop GW, Isada CM. Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine (Baltimore) 2003; 82 (2) 97-105
  CrossrefPubMedGoogle Scholar
• 2 Riddell IV J, Comer GM, Kauffman CA. Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents. Clin Infect Dis 2011; 52 (5) 648-653
  CrossrefPubMedGoogle Scholar
• 3 Lamaris GA, Esmaeli B, Chamilos G , et al. Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. Eur J Clin Microbiol Infect Dis 2008; 27 (5) 343-347
  CrossrefPubMedGoogle Scholar
• 4 Donahue SP, Greven CM, Zuravleff JJ , et al. Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology 1994; 101 (7) 1302-1309
  CrossrefPubMedGoogle Scholar
• 5 Oude Lashof AML, Rothova A, Sobel JD , et al. Ocular manifestations of candidemia. Clin Infect Dis 2011; 53 (3) 262-268
  CrossrefPubMedGoogle Scholar
• 6 Khan FA, Slain D, Khakoo RA. Candida endophthalmitis: focus on current and future antifungal treatment options. Pharmacotherapy 2007; 27 (12) 1711-1721
  CrossrefPubMedGoogle Scholar
• 7 Connell PP, O'Neill EC, Amirul Islam FM , et al. Endogenous endophthalmitis associated with intravenous drug abuse: seven-year experience at a tertiary referral center. Retina 2010; 30 (10) 1721-1725
  CrossrefPubMedGoogle Scholar
• 8 Leibovitch I, Lai T, Raymond G, Zadeh R, Nathan F, Selva D. Endogenous endophthalmitis: a 13-year review at a tertiary hospital in South Australia. Scand J Infect Dis 2005; 37 (3) 184-189
  CrossrefPubMedGoogle Scholar
• 9 Popovich K, Malani PN, Kauffman CA, Cinti SK. Compliance with Infectious Diseases Society of America guidelines for ophthalmologic evaluation of patients with candidemia. Infect Dis Clin Pract 2007; 15 (4) 254-256
  CrossrefPubMedGoogle Scholar
• 10 Shah CP, McKey J, Spirn MJ, Maguire J. Ocular candidiasis: a review. Br J Ophthalmol 2008; 92 (4) 466-468
  CrossrefPubMedGoogle Scholar
• 11 Krishna R, Amuh D, Lowder CY, Gordon SM, Adal KA, Hall G. Should all patients with candidaemia have an ophthalmic examination to rule out ocular candidiasis?. Eye (Lond) 2000; 14 (Pt 1) 30-34
  CrossrefPubMedGoogle Scholar
• 12 Kannangara S, Shindler D, Kunimoto DY, Sell B, DeSimone JA. Candidemia complicated by endophthalmitis: a prospective analysis. Eur J Clin Microbiol Infect Dis 2007; 26 (11) 839-841
  CrossrefPubMedGoogle Scholar
• 13 Karmisholt MK, Hjort U, Knudsen LL, Schønheyder HC. Candidaemia and risk of intraocular infection: a Danish hospital-based cohort study. Scand J Infect Dis 2008; 40 (3) 241-246
  CrossrefPubMedGoogle Scholar
• 14 Scherer WJ, Lee K. Implications of early systemic therapy on the incidence of endogenous fungal endophthalmitis. Ophthalmology 1997; 104 (10) 1593-1598
  CrossrefPubMedGoogle Scholar
• 15 Dozier CC, Tarantola RM, Jiramongkolchai K, Donahue SP. Fungal eye disease at a tertiary care center: the utility of routine inpatient consultation. Ophthalmology 2011; 118 (8) 1671-1676
  CrossrefPubMedGoogle Scholar
• 16 Lingappan A, Wykoff CC, Albini TA , et al. Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol 2012; 153 (1) 162-6.e1
  CrossrefPubMedGoogle Scholar
• 17 Blennow O, Tallstedt L, Hedquist B, Gårdlund B. Duration of treatment for candidemia and risk for late-onset ocular candidiasis. Infection 2013; 41 (1) 129-134
  CrossrefPubMedGoogle Scholar
• 18 Essman TF, Flynn Jr HW, Smiddy WE , et al. Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers 1997; 28 (3) 185-194
  PubMedGoogle Scholar
• 19 Pappas PG, Kauffman CA, Andes D , et al. Clinical practice guideline for the management of candidiasis: 2015 update by the Infectious Diseases Society of America. Clin Infect Dis 2015; ; In press
  PubMedGoogle Scholar
• 20 Chhablani J. Fungal endophthalmitis. Expert Rev Anti Infect Ther 2011; 9 (12) 1191-1201
  CrossrefPubMedGoogle Scholar
• 21 Hidalgo JA, Alangaden GJ, Eliott D , et al. Fungal endophthalmitis diagnosis by detection of Candida albicans DNA in intraocular fluid by use of a species-specific polymerase chain reaction assay. J Infect Dis 2000; 181 (3) 1198-1201
  CrossrefPubMedGoogle Scholar
• 22 Vinikoor MJ, Zoghby J, Cohen KL, Tucker JD. Do all candidemic patients need an ophthalmic examination?. Int J Infect Dis 2013; 17 (3) e146-e148
  CrossrefPubMedGoogle Scholar
• 23 Sallam A, Taylor SRJ, Khan A , et al. Factors determining visual outcome in endogenous Candida endophthalmitis. Retina 2012; 32 (6) 1129-1134
  CrossrefPubMedGoogle Scholar
• 24 Felton T, Troke PF, Hope WW. Tissue penetration of antifungal agents. Clin Microbiol Rev 2014; 27 (1) 68-88
  CrossrefPubMedGoogle Scholar
• 25 Martínez-Vázquez C, Fernández-Ulloa J, Bordón J , et al. Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy. Clin Infect Dis 1998; 27 (5) 1130-1133
  CrossrefPubMedGoogle Scholar
• 26 Zhang Y-Q, Wang W-J. Treatment outcomes after pars plana vitrectomy for endogenous endophthalmitis. Retina 2005; 25 (6) 746-750
  CrossrefPubMedGoogle Scholar
• 27 Gamaletsou MN, Kontoyiannis DP, Sipsas NV , et al. Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011). Clin Infect Dis 2012; 55 (10) 1338-1351
  CrossrefPubMedGoogle Scholar
• 28 Slenker AK, Keith SW, Horn DL. Two hundred and eleven cases of Candida osteomyelitis: 17 case reports and a review of the literature. Diagn Microbiol Infect Dis 2012; 73 (1) 89-93
  CrossrefPubMedGoogle Scholar
• 29 Neofytos D, Huprikar S, Reboli A , et al. Treatment and outcomes of Candida osteomyelitis: review of 53 cases from the PATH Alliance® registry. Eur J Clin Microbiol Infect Dis 2014; 33 (1) 135-141
  CrossrefPubMedGoogle Scholar
• 30 Malani PN, McNeil SA, Bradley SF, Kauffman CA. Candida albicans sternal wound infections: a chronic and recurrent complication of median sternotomy. Clin Infect Dis 2002; 35 (11) 1316-1320
  CrossrefPubMedGoogle Scholar
• 31 Hendrickx L, Van Wijngaerden E, Samson I, Peetermans WE. Candidal vertebral osteomyelitis: report of 6 patients, and a review. Clin Infect Dis 2001; 32 (4) 527-533
  CrossrefPubMedGoogle Scholar
• 32 Miller DJ, Mejicano GC. Vertebral osteomyelitis due to Candida species: case report and literature review. Clin Infect Dis 2001; 33 (4) 523-530
  CrossrefPubMedGoogle Scholar
• 33 Zimmerli W. Clinical practice. Vertebral osteomyelitis. N Engl J Med 2010; 362 (11) 1022-1029
  CrossrefPubMedGoogle Scholar
• 34 Hennequin C, Bourée P, Hiesse C, Dupont B, Charpentier B. Spondylodiskitis due to Candida albicans: report of two patients who were successfully treated with fluconazole and review of the literature. Clin Infect Dis 1996; 23 (1) 176-178
  CrossrefPubMedGoogle Scholar
• 35 Dan M, Priel I. Failure of fluconazole therapy for sternal osteomyelitis due to Candida albicans . Clin Infect Dis 1994; 18 (1) 126-127
  CrossrefPubMedGoogle Scholar
• 36 Legout L, Assal M, Rohner P, Lew D, Bernard L, Hoffmeyer P. Successful treatment of Candida parapsilosis (fluconazole-resistant) osteomyelitis with caspofungin in a HIV patient. Scand J Infect Dis 2006; 38 (8) 728-730
  CrossrefPubMedGoogle Scholar
• 37 Cornely OA, Lasso M, Betts R , et al. Caspofungin for the treatment of less common forms of invasive candidiasis. J Antimicrob Chemother 2007; 60 (2) 363-369
  CrossrefPubMedGoogle Scholar
• 38 Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis 2001; 32 (1) 50-62
  CrossrefPubMedGoogle Scholar
• 39 Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest 2002; 122 (1) 302-310
  CrossrefPubMedGoogle Scholar
• 40 Baddley JW, Benjamin Jr DK, Patel M , et al; International Collaboration on Endocarditis-Prospective Cohort Study Group (ICE-PCS). Candida infective endocarditis. Eur J Clin Microbiol Infect Dis 2008; 27 (7) 519-529
  CrossrefPubMedGoogle Scholar
• 41 Benjamin Jr DK, Miro JM, Hoen B , et al; ICE-MD Study Group. Candida endocarditis: contemporary cases from the International Collaboration of Infectious Endocarditis Merged Database (ICE-mD). Scand J Infect Dis 2004; 36 (6-7) 453-455
  CrossrefPubMedGoogle Scholar
• 42 Falcone M, Barzaghi N, Carosi G , et al; Italian Study on Endocarditis. Candida infective endocarditis: report of 15 cases from a prospective multicenter study. Medicine (Baltimore) 2009; 88 (3) 160-168
  CrossrefPubMedGoogle Scholar
• 43 Lefort A, Chartier L, Sendid B , et al; French Mycosis Study Group. Diagnosis, management and outcome of Candida endocarditis. Clin Microbiol Infect 2012; 18 (4) E99-E109
  CrossrefPubMedGoogle Scholar
• 44 Smego Jr RA, Ahmad H. The role of fluconazole in the treatment of Candida endocarditis: a meta-analysis. Medicine (Baltimore) 2011; 90 (4) 237-249
  CrossrefPubMedGoogle Scholar
• 45 Tacke D, Koehler P, Cornely OA. Fungal endocarditis. Curr Opin Infect Dis 2013; 26 (6) 501-507
  CrossrefPubMedGoogle Scholar
• 46 Boland JM, Chung HH, Robberts FJ , et al. Fungal prosthetic valve endocarditis: Mayo Clinic experience with a clinicopathological analysis. Mycoses 2011; 54 (4) 354-360
  CrossrefPubMedGoogle Scholar
• 47 Nasser RM, Melgar GR, Longworth DL, Gordon SM. Incidence and risk of developing fungal prosthetic valve endocarditis after nosocomial candidemia. Am J Med 1997; 103 (1) 25-32
  CrossrefPubMedGoogle Scholar
• 48 Halawa A, Henry PD, Sarubbi FA. Candida endocarditis associated with cardiac rhythm management devices: review with current treatment guidelines. Mycoses 2011; 54 (4) e168-e174
  CrossrefPubMedGoogle Scholar
• 49 Card L, Lofland D. Candidal endocarditis presenting with bilateral lower limb ischemia. Clin Lab Sci 2012; 25 (3) 130-134
  PubMedGoogle Scholar
• 50 Donal E, Abgueguen P, Coisne D , et al. Echocardiographic features of Candida species endocarditis: 12 cases and a review of published reports. Heart 2001; 86 (2) 179-182
  CrossrefPubMedGoogle Scholar
• 51 Nguyen MH, Nguyen ML, Yu VL, McMahon D, Keys TF, Amidi M. Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature. Clin Infect Dis 1996; 22 (2) 262-267
  CrossrefPubMedGoogle Scholar
• 52 Chu VH, Bayer AS. Use of echocardiography in the diagnosis and management of infective endocarditis. Curr Infect Dis Rep 2007; 9 (4) 283-290
  CrossrefPubMedGoogle Scholar
• 53 Cornely OA, Bassetti M, Calandra T , et al; ESCMID Fungal Infection Study Group. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 2012; 18 (Suppl. 07) 19-37
  CrossrefPubMedGoogle Scholar
• 54 Steinbach WJ, Perfect JR, Cabell CH , et al. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect 2005; 51 (3) 230-247
  CrossrefPubMedGoogle Scholar
• 55 Tascini C, Bongiorni MG, Tagliaferri E , et al. Micafungin for Candida albicans pacemaker-associated endocarditis: a case report and review of the literature. Mycopathologia 2013; 175 (1-2) 129-134
  CrossrefPubMedGoogle Scholar
• 56 Bacak V, Biocina B, Starcevic B, Gertler S, Begovac J. Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient—case report and review of literature. J Infect 2006; 53 (1) e11-e14
  CrossrefPubMedGoogle Scholar
• 57 Lye DC, Hughes A, O'Brien D, Athan E. Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. Eur J Clin Microbiol Infect Dis 2005; 24 (11) 753-755
  CrossrefPubMedGoogle Scholar
• 58 De Rosa FG, D'Avolio A, Corcione S , et al. Anidulafungin for Candida glabrata infective endocarditis. Antimicrob Agents Chemother 2012; 56 (8) 4552-4553
  CrossrefPubMedGoogle Scholar